Microbiology

Napyradiomycin C2 is an antibiotic that primarily targets Gram-positive bacteria and mycobacteria. It exhibits significant antibacterial activity, making it a valuable compound for research focused on bacterial infections and resistance mechanisms. Its unique structure and mode of action can facilitate studies in drug development and microbiology.

Rac N-Demethyl promethazine hydrochloride is a metabolite of Phenothiazine, targeting various biological pathways. This compound exhibits antibiotic properties, demonstrating insecticidal, fungicidal, antibacterial, and anthelmintic activities. It is utilized in research applications focused on understanding mechanisms of action in microbial resistance and therapeutic efficacy.

44-Homooligomycin B is an antitumor antibiotic that primarily targets fungal infections. It exhibits potent activity against fungal strains, including Aspergillus, Penicillium, and Fusarium, while lacking effectiveness against yeast and bacteria. Additionally, 44-Homooligomycin B demonstrates moderate antitumor activity in vivo against Colon 26 cancer models, making it a valuable compound for research in oncology and mycology.

RU44790 is a monocyclic beta-lactam antibiotic that demonstrates potent efficacy against gram-negative bacteria and exhibits remarkable resistance to hydrolysis by various beta-lactamases. This compound serves as a valuable tool in antibacterial research, facilitating investigations into bacterial resistance mechanisms and the development of novel therapeutic strategies.

Coumamidine γ2 is an alkaline sugar antibiotic known for its broad-spectrum antibacterial activity, particularly against Pseudomonas aeruginosa. This compound demonstrates efficacy in inhibiting bacterial growth and is valuable for research applications involving antibiotic resistance and infection models. Its unique mechanism offers insights into microbial interactions and potential therapeutic approaches in clinical settings.

Valanimycin is an antibiotic that targets Escherichia coli by interacting with DNA, effectively inhibiting bacterial growth. In addition to its antibacterial properties, Valanimycin demonstrates cytotoxic effects against mouse leukemia cell lines, including L1210, P388/S, and P388/ADR, with IC50 values of 0.79, 2.65, and 1.44 μg/mL, respectively. It also exhibits significant antitumor efficacy in models of ehrlich ascites tumors and L1210 cells in mice, making it a valuable compound for cancer research and antibiotic studies.

Napyradiomycin B1 is an antibiotic that exhibits potent activity against Gram-positive bacteria and mycobacteria. It demonstrates minimal effectiveness against Gram-negative bacteria and fungi. The compound has an IC50 of 2.2 μg/mL in leukemia L-1210 cell lines, highlighting its potential for research in cancer and infectious disease studies.

Nikkomycin Lx is an antibiotic derived from Streptomyces tendae TU901, targeting the inhibition of fungal cell wall synthesis. It exhibits significant anti-Candida albicans activity, making it valuable for studies focused on fungal infections and resistance mechanisms. This reagent is suitable for research applications involving antifungal efficacy and related therapeutic investigations.

Maridomycin IV is a macrolide antibiotic that targets Gram-positive bacteria and mycoplasma. Demonstrating potent antibacterial activity, it effectively protects mice from Gram-positive bacterial infections. This compound is useful in research applications focused on evaluating antibiotic efficacy and understanding bacterial resistance mechanisms.

Cytorhodin X is a cytotoxic antibiotic that targets bacterial and cancer cell proliferation. It effectively inhibits the growth of L1210 murine leukemia cells, demonstrating an ED50 value of 0.36 μM. This compound is valuable for research applications involving cancer treatment and antibiotic efficacy studies.

Micacocidin C is an antibiotic derived from Pseudomonas sp. No. 57, primarily targeting Mycoplasma species. It demonstrates potent antibacterial activity, making it valuable for research applications focused on combating mycoplasmal infections and understanding antibiotic resistance mechanisms.

Cryptosporiopsin is a potent antibacterial agent derived from Cryptosporiopsis sp. and Sporormia affinis. This compound exhibits significant antibacterial activity against a variety of fungi, including basidiomycetes, algal fungi, ascomycetes, and hemiplegia fungi responsible for wood rot. Additionally, Cryptosporiopsin has been shown to inhibit the spore germination of Phytophthora species affecting potatoes, and demonstrates activity against both gram-positive and gram-negative bacteria, making it valuable for antibacterial research applications.

Baumycin A1 is an antitumor antibiotic that primarily exerts its effects through the inhibition of DNA synthesis. It demonstrates significant cytotoxic activity against various cancer cell lines, making it a valuable tool for cancer research. Researchers can utilize Baumycin A1 to explore mechanisms of tumorigenesis and to develop novel therapeutic strategies in oncology.

Sannamycin F is an aminoglycoside antibiotic that primarily targets bacterial protein synthesis. It exhibits weak antibacterial activity against both Gram-positive and Gram-negative bacteria. This compound is suitable for studies focusing on antibiotic resistance mechanisms and the development of new antimicrobial agents.

Platenomycin C3 is a macrolide antibiotic that targets Gram-positive bacteria through inhibition of bacterial fatty acid synthesis. Exhibiting potent antimicrobial activity, it is particularly effective against various strains of resistant pathogens. This compound serves as a valuable research tool for studies focused on antibiotic resistance and bacterial metabolism.

1-Hydroxysulfurmycin A is an anthracycline antibiotic that exerts its primary activity through the intercalation of DNA, disrupting replication and transcription processes. This compound demonstrates significant antitumor properties and exhibits activity against Gram-positive bacteria. It is primarily utilized in cancer research and studies focused on bacterial resistance mechanisms.

Ticarcillin monosodium is a semisynthetic, extended-spectrum carboxypenicillin with notable antibacterial activity targeting gram-positive cocci, such as streptococci and staphylococci, as well as a broad range of gram-negative organisms, including Pseudomonas aeruginosa. This compound is utilized in research related to lower respiratory tract infections, skin and skin structure infections, urinary tract infections, and intraabdominal infections. Its diverse spectrum of activity makes it a valuable tool for studying various infectious diseases.

Pyrrolosporin A is an antibiotic that exhibits activity against Gram-negative bacteria. It demonstrates weak bactericidal properties, making it of interest in studies focused on antibiotic resistance and the mechanisms of bacterial infection. This compound can serve as a valuable tool in research aimed at developing new antimicrobial therapies.

Mureidomycin A is an antibiotic that exhibits potent activity against Pseudomonas aeruginosa. This compound inhibits bacterial protein synthesis, making it a valuable tool in studying bacterial resistance and developing new therapeutic strategies. Its specific targeting of pathogenic bacteria supports research in infectious disease and antibiotic development.

Neutramycin is a neutral macrolide antibiotic that targets bacterial protein synthesis by binding to the 50S ribosomal subunit. It exhibits broad-spectrum antimicrobial activity, making it effective against a variety of Gram-positive and Gram-negative bacteria. This compound is utilized in research applications focused on antibiotic resistance, mechanisms of action in microbial physiology, and the development of new therapeutic strategies.

Promothiocin B is an antibiotic that primarily targets bacterial cell wall synthesis. It exhibits potent antibacterial activity with a minimum induction concentration of 0.1 μg/mL for the tipA promoter. This compound is valuable for research applications involving the study of antibiotic mechanisms and resistance, as well as in the development of novel therapeutic strategies against bacterial infections.

Griseoviridin is an Estopeptide antibiotic that primarily targets bacterial cell wall synthesis. This compound exhibits potent activity against Gram-positive bacteria and demonstrates selective effects on certain Gram-negative bacteria. It is useful in research applications involving antimicrobial susceptibility testing and the study of antibiotic resistance mechanisms.

Pyrisulfoxin B is an antibiotic derived from the bacterium Streptomyces callfornicus BS-75. It exhibits significant antibacterial activity, making it suitable for research focused on antimicrobial agents and their mechanisms of action. Pyrisulfoxin B can be utilized in studies investigating antibiotic resistance and developing novel therapeutic strategies.

Tetromycin C5 is a broad-spectrum antibiotic targeting gram-positive bacteria, including strains that exhibit drug resistance. It demonstrates significant antibacterial activity, making it a valuable tool for research in infectious disease and antibiotic resistance studies. This compound is ideal for exploring mechanisms of antimicrobial action and developing novel therapeutic strategies.

Collinone is a recombinant angular polyketide antibiotic that exhibits antibacterial activity primarily against gram-positive bacteria. In addition to its antimicrobial properties, Collinone demonstrates cytotoxic effects, making it a valuable compound for research in microbial resistance and bioactivity studies. Its unique structure and mechanism of action provide insights into antibiotic development and potential therapeutic applications.

Gepotidacin hydrochloride is a novel antibacterial agent that inhibits bacterial type II topoisomerases. By interfering with DNA replication and repair processes, it exhibits potent activity against a range of Gram-negative and Gram-positive bacteria. This compound is primarily utilized in research focused on bacterial infections and the development of new antibacterial therapies.

Polymyxin T1 is an antibiotic derived from Bacillus polymyxa E-12, primarily targeting Gram-negative bacteria. It exhibits bactericidal activity by disrupting the bacterial cell membrane, leading to cell lysis. Due to its specific action, Polymyxin T1 is valuable for research in studying bacterial resistance and exploring new antimicrobial strategies.

Seldomycin factor 3 is an aminoglycoside antibiotic that exhibits a broad spectrum of antimicrobial activity. It is primarily used in research applications to investigate mechanisms of bacterial resistance and to study antibiotic efficacy against various microbial strains. This compound serves as a valuable tool in the development of new therapeutic strategies to combat infectious diseases.

Fluopsin F is an antitumor antibiotic that demonstrates significant antibacterial properties against both Gram-positive and Gram-negative bacteria. Its unique composition containing metallic iron contributes to its efficacy in targeting and inhibiting tumor growth. Fluopsin F is suitable for research applications focused on cancer treatment and antibiotic resistance studies.

Hormaomycin is a potent and selective macrocyclic antibiotic agent that targets bacterial cell membranes. It exhibits broad-spectrum antibiotic activity against various Gram-positive bacteria. This compound is valuable for research applications focused on bacterial resistance mechanisms and the development of novel antimicrobial therapies.

3-Hydroxyrifamycin S is an Ansamycin antibiotic that targets bacterial ribosomes to inhibit protein synthesis. This compound exhibits significant activity against Gram-positive bacteria while demonstrating weaker efficacy against Gram-negative bacteria. It is primarily utilized in research focused on antibiotic resistance and the mechanisms of bacterial infection.

Gentamicin B is an aminoglycoside antibiotic derived from Micromonospora echinospora. It exhibits potent antibacterial activity against a broad spectrum of Gram-negative bacteria. This compound is primarily utilized in research focusing on its potential for inducing ataxia and evaluating renal toxicity.

Amythiamicin D is a thiopeptide antibiotic that primarily targets Gram-positive bacteria, effectively inhibiting their growth. It demonstrates significant antibacterial activity and is utilized in research applications focusing on bacterial resistance mechanisms and the exploration of novel antimicrobial agents. This compound serves as a valuable tool for investigating the pharmacological properties and therapeutic potential of thiopeptide antibiotics.

Saroaspidin C is an antibiotic compound derived from Sarothra japonica. It exhibits potent antibacterial activity, making it a valuable tool for research in microbiology and infectious disease studies. This compound can be utilized to investigate mechanisms of action against bacterial pathogens and to explore new therapeutic strategies for treating infections.

Kapurimycin A1 is an antitumor antibiotic derived from Streptomyces species. It displays potent inhibitory activity against Gram-positive bacteria and exhibits cytotoxic effects on cultured mammalian cells. Additionally, Kapurimycin A1 has demonstrated strong antitumor efficacy against the mouse leukemia P388 cell line, making it a valuable tool for cancer research studies.

Napsamycin D is an antibiotic that targets bacterial cell growth. It exhibits strong antibacterial activity specifically against Pseudomonas aeruginosa and other Pseudomonas species, while displaying limited efficacy against other Gram-positive and Gram-negative bacteria. This compound is useful in research settings focused on bacterial infections and antibiotic resistance studies.

Macquarimicin B is an antibiotic that primarily targets bacterial RNA synthesis. It exhibits potent antibacterial activity against a range of Gram-positive bacteria, making it valuable in the study of antibiotic resistance and bacterial pathogenesis. This compound is applicable in research focused on the mechanisms of action of antibiotics and the development of novel therapeutic agents for bacterial infections.

Atrovenetin is an antibiotic derived from Penicillium species that primarily targets bacterial infections. It demonstrates inhibitory activity against Bacillus subtilis and Staphylococcus aureus, making it relevant for studies on bacterial resistance and antibiotic efficacy. Additionally, Atrovenetin exhibits potent antioxidant properties, contributing to its potential use in research focused on oxidative stress and related biological pathways.

Polymyxin A2 is a heteropeptide antibiotic that targets the outer membrane of Gram-negative bacteria, disrupting membrane integrity and leading to cell death. It exhibits stronger antibacterial activity against Gram-negative strains compared to Gram-positive counterparts. Polymyxin A2 is primarily used in microbiological research to study antibiotic resistance mechanisms and to evaluate the efficacy of new antimicrobial agents.

Baumycin B1 is an antitumor antibiotic that functions by inhibiting DNA synthesis and disrupting cellular replication. This compound exhibits significant cytotoxicity against a variety of cancer cell lines, making it a valuable tool for cancer research. Its mechanism of action offers potential insights into therapeutic strategies for tumor treatment and provides a basis for further investigation into its biological effects.

Aspergillic acid is an antibiotic derived from Aspergillus flavus, primarily targeting bacterial pathogens. It exhibits a broad spectrum of antibacterial activity, making it a valuable reagent for microbiological studies. Aspergillic acid is often utilized in research applications focused on antibiotic resistance and the development of new antimicrobial agents.

Propionylmaridomycin is a macrolide antibiotic that exhibits potent antibacterial activity. Following oral administration, it is rapidly absorbed and distributed to various tissues, demonstrating significantly higher concentration levels in the liver, kidneys, and lungs compared to plasma. Its superior antibacterial efficacy is particularly noted in pulmonary tissue, and it is predominantly excreted through feces. In metabolic studies on rats, Propionylmaridomycin is extensively metabolized, with 4''-depropionyl-9-propionylmaridomycin identified as the principal metabolite. This compound is valuable for research into antibiotic effectiveness and microbial resistance mechanisms.

Ericamycin is a potent antibiotic that targets Gram-positive bacteria, demonstrating significant antibacterial activity. It effectively inhibits the growth of Staphylococcus aureus with a minimal inhibitory concentration (MIC) range of 0.004 to 0.016 µg/mL. This compound is valuable for research focused on antibiotic resistance and the study of bacterial infections.

7β,8β-Epoxyroridin H is an antibiotic targeting a wide range of bacterial strains. It exhibits significant activity against both Gram-positive and Gram-negative bacteria, making it a valuable tool in antimicrobial research. This compound is suitable for studies investigating bacterial resistance mechanisms and the development of novel antibacterial therapies.

Fluvirucin B5 is an antibiotic that specifically targets the influenza A virus. This compound exhibits potent antiviral activity, making it valuable for research into influenza infections and the mechanisms of antiviral resistance. It is useful in studies aimed at understanding viral pathogenesis and developing therapeutic strategies against influenza A.

Parvodicin B2 is a glycopeptide antibiotic that targets bacterial cell wall synthesis. This compound exhibits potent inhibitory activity against Staphylococcus aureus, Staphylococcus furfur, Staphylococcus hemolyticus, and Enterococcus faecalis. Parvodicin B2 is valuable for research applications focusing on antibiotic resistance and bacterial infections.

Epithienamycin C is a carbapenem antibiotic that exhibits strong activity against both Gram-positive and Gram-negative bacteria. This compound targets bacterial cell wall synthesis, making it effective in various microbiological research applications. Its broad-spectrum efficacy positions it as a valuable reagent for studies exploring antibiotic mechanisms and resistance.

Griseorhodin G is a quinone antibiotic known for its ability to inhibit bacterial growth. This compound exhibits notable antitumor activity, making it relevant for cancer research applications. Its unique mechanism of action may offer insights into developing new therapeutic strategies against resistant microbial strains and cancer cells.

Miyakamide B1 is an antitumor antibiotic that exerts its effects through the inhibition of cellular growth. It demonstrates notable cytotoxicity against P388 leukemia cells, exhibiting an IC50 value of 8.8 μg/mL. Additionally, Miyakamide B1 displays insecticidal properties, contributing to its potential applications in both cancer research and agricultural pest management. This compound may serve as a valuable tool for studies focused on antitumor mechanisms and insecticidal activity.

Butylcycloheptylprodigiosin is a red-pigmented antibiotic derived from bacterial secondary metabolism, particularly from strains of Streptomyces. This compound displays significant cytotoxicity against cancer cell lines, including MCF-7, and also affects human dermal fibroblasts (HDF). Its antibacterial properties make it a valuable tool for research into novel antimicrobial therapies and cancer treatment strategies.